Patients Discontinuing Anti-Obesity Medications Put On Pounds Far More Rapidly Compared to Those on Conventional Diets

New research indicates that individuals who discontinue popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight much more quickly than those who stop traditional diet and exercise programs.

Published data in a prominent health publication shows that while obese individuals frequently drop a large proportion of their body weight while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"Users using these drugs should be aware of the danger of fast weight regain when the therapy ends," cautioned expert Dr. Susan Jebb.

This pace of regain implies a reversion to pre-treatment weight within about 18 months.

Analyzing Approaches

The analysis, which examined dozens of studies involving thousands of patients, contrasted the results of these new drugs with conventional dieting.

The team note that individuals who lose weight through lifestyle changes alone typically have a slower creep back—perhaps 100 grams monthly—post-intervention.

The Reason for the Fast Regain

Experts suggest the mechanism of the drugs is key to understanding the accelerated regain.

GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone levels several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication leads to hunger is unsuppressed, making overeating a significant risk."

A Lifelong Condition?

The NHS suggest the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians argue that, considering the significant potential of weight regain, the therapy is often long-term.

This perspective is echoed by drug manufacturers, who say that the results "underscore the persistent nature of obesity," similar to managing diseases like diabetes.

Patient Accounts

Individuals who have stopped the jabs describe a intense resurgence of hunger.

"I experienced something that goes on and you're instantly ravenous," recalled an individual.

This difficulty is worsened if users have not adopted sustainable lifestyle or habit changes during therapy.

Widespread Use

Figures show that a significant number of people in the UK have tried these injections in the past year, with desire continuing to grow.

• Use is more common among females compared to men.
• The middle-aged age group shows the greatest level of interest.
• Many obtain the drugs through private prescriptions rather than public health services.

Ultimately, clinicians emphasize that while these medications are effective tools for weight loss, they are not a magic solution and lasting health benefits hinges on integrated lifestyle management.